Lead, Immunology Innovation, Johnson & Johnson Innovation, London
Jason Witherington is the Immunology Innovation Lead for Johnson & Johnson Innovation and is located at the Innovation Centre in London. In this role, he is responsible for growing the immunology academic and industry network in EMEA and to identify and advance external opportunities in the field of immunology.
Prior to joining Johnson & Johnson Innovation he worked for Galvani Bioelectronics (a GSK/Google-Verily funded company) where, as Vice President and Head of Translational Sciences, he was the founding member responsible for establishing a unit in the emerging field of peripheral neuromodulation for controlling immune homeostasis. This unit created and delivered scientific strategies for advancing projects from early inception through to clinical stage programs.
Prior to this, Jason spent nearly 20 years at GSK in the fields of neurology, oncology and immunology. His most recent role was Vice President and Discovery Performance Unit Head within the immuno-inflammation therapy area unit, responsible for leading multidisciplinary teams to identify and advance projects from early target validation through to clinical proof of concept. He received his Ph.D. in Organic Chemistry from the University of Reading, UK, and completed his post-doctoral work in Bioorganic Chemistry at the University of Pennsylvania, USA.